Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Supporters often stress the opportunity for meaningful therapeutic gains, principally in diseases where conventional therapies have proven ineffective. However, this is to evaluate the significant financial expenditure associated with CPI stem web